The lymphocytes that produce interleukin-17 (IL-17) are involved in the triggering of immune disorders such as multiple sclerosis (MS). This project aims to identify the factors involved in the differentiation of the lymphocyte population and assess their use as potential biomarkers of the activity of the disease. A second aspect of the project will consist of studying the effect of a treatment neutralising IL-17 on an MS mouse experimental model.